The Role of a Single Angiogenesis Inhibitor in the Treatment of Recurrent Glioblastoma Multiforme: A Meta-Analysis and Systematic Review.
<h4>Background</h4>Currently, the standard treatment for newly diagnosed glioblastoma multiforme (GBM) is maximal safe surgical resection followed by radiation therapy with concurrent and adjuvant temozolomide. However, disease recurs in almost all patients, and the optimal salvage treat...
Saved in:
Main Authors: | Yawei Wang, Dan Xing, Meng Zhao, Jie Wang, Yang Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0152170&type=printable |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Genetics and Biology of Glioblastoma Multiforme
by: Carmo, Anália, et al.
Published: (2011) -
Angiogenesis inhibition on glioblastoma multiforme cell lines (U-87 MG and T98G) by AT-101
by: Burcu Cakar, et al.
Published: (2018-08-01) -
Clinical outcome of patients with glioblastoma multiforme: Single center experience
by: Özlem Yersal
Published: (2017-12-01) -
A PANoptosis‐Based Signature for Survival and Immune Predication in Glioblastoma Multiforme
by: Jun Yang, et al.
Published: (2025-07-01) -
Wnt-signaling pathway in pathogenesis of glioblastoma multiforme
by: Yu. D. Vasilets, et al.
Published: (2019-01-01)